Are Medibank Private Ltd shares worth $2.59?

If you acquired shares in private health insurer Medibank Private Ltd (ASX: MPL) during last year’s initial public offering (IPO) you’re currently sitting on a tidy paper profit and a return that is around 10% better than what the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has achieved.

One of the many challenges investors face is overcoming a tendency to “anchor”.

Anchoring can take many forms. For example, perhaps you bought into resource stocks at the height of the mining boom and unfortunately lost money. This experience could lead you to swear off buying another mining stock ever again – it’s an understandable stance to take.

The similar scenario could have happened to investors who owned technology stocks at the turn of the century which soared to unbelievable heights before crashing back down to earth.

Unfortunately, in both instances deciding to never invest in a whole sector again because of a bad investment experience might mean you miss out on numerous profitable future opportunities. It could also mean you don’t get to utilise valuable knowledge you have gained along the way!

Another area where anchoring can occur is with regards to a price level.

For example, identifying an attractive investment opportunity only to see the share price move higher before you purchase the stock can lead to a fixation of buying at that prior price level even though the investment merits may still be favourable at the higher price too.

The reverse of this situation can happen too. Consider Medibank Private for instance…

It’s possible that many shareholders of the stock don’t believe there is much upside in the stock from this point, perhaps some shareholders are not even sure what the stock is really worth.

What they probably do know however is: the price they paid for the stock ($2 a share), the price the shares are currently trading at (around $2.30), and the highest price the shares have reached since the IPO ($2.59).

With the share price trading on a forward price-to-earnings (PE) ratio in the vicinity of 18x the stock is perhaps not wildly expensive, but nor is it a bargain. At $2.59 that PE multiple would expand to around 20x.

Some shareholders may be quite happy owning Medibank Private at these levels, however, those that have identified better investment opportunities would arguably be well advised to not anchor to a higher price level before selling.

DID YOU KNOW... The Motley Fool's top analysts have just completed a brand-new free report on their top pick for 2015. Be among the first to get the name and code right now. (Hint: It's a sexy ASX tech company!) Simply click here for your FREE copy... BEFORE the investing crowd gets wind of this!

Motley Fool contributor Tim McArthur has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.